In 2015, there were 177 networked self-help groups of people living with HIV; there was no update as of September 2018. HIV and tuberculosis (TB) coinfection in Myanmar. Myanmar is one of 14 countries that carry a high burden of TB/HIV coinfection (of 30 countries globally) as well as multi-drug resistant TB and TB infection. Nov 06, 2018 PHOE PYAE KO SAUNT NAT (ဖုိ႕ျပည့္ - ကုိယ္ေစာင့္နတ္) with lyric, Myanmar Latest Song 2018 - Duration: 4:37. Bean Brother 1,905,929 views 4:37.
About us Who We AreLearn about our mission, our charter and principles, and who we are. How we workSee what triggers an intervention and how supply and logistics allow our teams to respond quickly. How we're runDiscover our governance and what it means to be an association.
Find a quick visual guide to our offices around the world. Reports and financialsRead through our annual financial and activity reports, and find out about where our funds come from and how they are spent. Contact usVisit this section to get in touch with our offices around the world. Other Sites MSF AssociationOur staff “own” and manage MSF, making sure that we stay true to our mission and principles, through the MSF Associations. Access CampaignWe set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond. Staff blogsRead stories from our staff as they carry out their work around the world. Patient blogsHear directly from the inspirational people we help as they talk about their experiences dealing with often neglected, life-threatening diseases.
CRASHBased in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field. UREPHBased in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action. ARHPBased in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.
MSF AnalysisBased in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates. Speaking OutRead through case studies where we openly examine and analyse all our actions and decision-making processes during humanitarian emergencies that have led us to speak out.
MSF SupplyThis logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions. MSF LogistiqueThis supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.
Amsterdam Procurement UnitThis logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements. Southern Africa Medical UnitSAMU provides strategic, clinical and implementation support to various MSF projects with medical activities related to HIV and TB. This medical unit is based in Cape Town, South Africa. Brazilian Medical UnitBRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil. MSF Medical GuidelinesOur medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
MSF Field ResearchFind important research based on our field experience on our dedicated Field Research website. Manson UnitThe Manson Unit is a London, UK-based team of medical specialists who provide medical and technical support, and conduct research for MSF. EpicentreProviding epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation UnitsEvaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work. LUXORThe Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.
Intersectional Benchmarking UnitThe Intersectional Benchmarking Unit collects and analyses data about local labour markets in all locations where MSF employs people. MSF Academy for HealthcareTo upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare. Humanitarian LawThis Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries. MSF Paediatric DaysThe MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field. MSF FoundationThe MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole. DNDiA collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
Insein clinic is one of two MSF clinics in Yangon, where MSF provides treatment for HIV, TB, and hepatitis C. In 2017, MSF provided care to 13,138 patients with HIV, TB or multidrug-resistant TB (MDR-TB) at the two clinics. 42 patients co-infected with HIV started MDR-TB treatment, 21 patients started extensively drug-resistant TB treatment (as part of the endTB programme, currently 33 patients are on treatment) and the team initiated hepatitis C treatment to 197 HIV-positive patients.Alessandro Penso/MAPS. Kay Thi Soe, 30, from Myammar, inside the MSF's Insein clinic in Yangon. Kay Thi Soe lives in Yangon with her husband and has been coming to the MSF clinic since 2014 when she tested positive for HIV. In 2016, she discovered that she has MDR-TB.
At one point during her treatment course, she was hospitalised for 4 months because her potassium level was too low. She lost a lot of weight, and was afraid that she was going to die. But the doctors and nurses took care of her and encouraged her to continue with treatment. When we met her, she was one month away from completing treatment for MDR-TB, and was very excited. “The first thing I want to do is tell my friends that I am OK and that treatment works.” She used to organise domestic tours around Myanmar, but hasn't been able to travel because she has to come to the clinic every day.
Now she is really looking forward to starting work again.Alessandro Penso/MAPS. Maung Maung Than, 35, from Myammar inside the MSF's Insein clinic in Yangon. Maung Maung Than is from Thon Sein and in 2017, was hospitalised due to a motorbike accident near Bagan. At first, he was in a hospital bed near other patients. After the results of his blood test came back, the doctors moved him to a far corner away from the other patients. He didn't know what was going on, until the doctor explained to him that he had tested positive for HIV.
At first, he felt very insecure and was shocked because he didn't feel any symptoms of HIV. He opened up to his friends, and some of them who are also living with HIV, encouraged him to get treatment. They told him that he can live a long life if you take the medications.
He had known about MSF's clinic because he used to be a bus caller and bike taxi driver, so he came to Insein clinic to get treatment. He's been on treatment now for nine months, and his condition is stable. This means he only has to come to the clinic every 3 months to pick up his medications, and has an annual check-up with his medical team.Alessandro Penso/MAPS.
Myanmar is missing more than 27% of its 191,000 people estimated to have developed drug-sensitive TB in 2016. During the same year, more than 80% of its 13,000 people estimated to have developed drug-resistant TB were also missed by the health system.To find more of its missing people, Myanmar is strengthening four approaches to increase TB case detection and early treatment of missing people with TB. The country is expanding access to GeneXpert in all townships and is ensuring proper use of GeneXpert and DST in line with the national policy (particularly for all smear positive and retreatment cases). Sputum transportation to the GeneXpert sites will be further strengthened and also builds on locally tailored referral systems.
Myanmar is further establishing 132 new and externally quality assured microscopy centers in station hospitals to improve access to TB diagnosis in rural and remote populations. Access to district-level GeneXpert for every township will be ensured through improved specimen transportations and referrals. Access to chest X-ray will also be facilitated in every township.A stronger emphasis is also given to engagement of private health care providers, particularly through the introduction of mandatory TB case notification, strengthened referrals from non-NTP providers as well as through the provision of DST provided to TB patients at risk of MDR-TB regardless of their treatment provider. Moreover, Myanmar is expanding active case detection through the deployment of 14 mobile digital chest X-ray teams.
Identification and referral of people with presumptive TB will be ensured by integrated community health workers and community volunteers in hard to reach populations.